GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently gaining a prominent focus in therapeutic investigation, largely due to its impressive impact on controlling conditions such as type 2 diabetes and weight gain. New trials have revealed that beyond glucose control, GLP-1 agon